These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11429215)

  • 1. Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: a Phase II trial for the Trans-Tasman Radiation Oncology Group.
    Ngan SY; Burmeister BH; Fisher R; Rischin D; Schache DJ; Kneebone A; MacKay JR; Joseph D; Bell A; Goldstein D
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):883-7. PubMed ID: 11429215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
    Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising results of a cooperative group phase II trial of preoperative chemoradiation for locally advanced rectal cancer (TROG 9801).
    Ngan SY; Fisher R; Burmeister BH; Mackay J; Goldstein D; Kneebone A; Schache D; Joseph D; McKendrick J; Leong T; McClure B; Rischin D
    Dis Colon Rectum; 2005 Jul; 48(7):1389-96. PubMed ID: 15906126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer.
    Videtic GM; Fisher BJ; Perera FE; Bauman GS; Kocha WI; Taylor M; Vincent MD; Plewes EA; Engel CJ; Stitt LW
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):319-24. PubMed ID: 9788410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer: preliminary results.
    Tjandra JJ; Reading DM; McLachlan SA; Gunn IF; Green MD; McLaughlin SJ; Millar JL; Pedersen JS
    Dis Colon Rectum; 2001 Aug; 44(8):1113-22. PubMed ID: 11535850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
    Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy.
    Marsh RD; Chu NM; Vauthey JN; Mendenhall WM; Lauwers GY; Bewsher C; Copeland EM
    Cancer; 1996 Jul; 78(2):217-25. PubMed ID: 8673995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer.
    Janjan NA; Crane CN; Feig BW; Cleary K; Dubrow R; Curley SA; Ellis LM; Vauthey J; Lenzi R; Lynch P; Wolff R; Brown T; Pazdur R; Abbruzzese J; Hoff PM; Allen P; Brown B; Skibber J
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):713-8. PubMed ID: 10837955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon.
    Czito BG; Hong TJ; Cohen DP; Tyler DS; Lee CG; Anscher MS; Ludwig KA; Seigler HF; Mantyh C; Morse MA; Lockhart AC; Petros WP; Honeycutt W; Spector NL; Ertel PJ; Mangum SG; Hurwitz HI
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):779-85. PubMed ID: 14967434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum.
    Rullier E; Goffre B; Bonnel C; Zerbib F; Caudry M; Saric J
    Ann Surg; 2001 Nov; 234(5):633-40. PubMed ID: 11685026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
    Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
    Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer.
    Mehta VK; Poen J; Ford J; Edelstein PS; Vierra M; Bastidas AJ; Young H; Fisher G
    Dis Colon Rectum; 2001 Jan; 44(1):52-8. PubMed ID: 11805563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience.
    Janjan NA; Khoo VS; Abbruzzese J; Pazdur R; Dubrow R; Cleary KR; Allen PK; Lynch PM; Glober G; Wolff R; Rich TA; Skibber J
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1027-38. PubMed ID: 10421535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer.
    Ngan SY; Michael M; Mackay J; McKendrick J; Leong T; Lim Joon D; Zalcberg JR
    Br J Cancer; 2004 Sep; 91(6):1019-24. PubMed ID: 15305186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative radiation with concurrent 5-fluorouracil for locally advanced T4-primary rectal cancer.
    Rödel C; Grabenbauer GG; Schick C; Papadopoulos T; Hohenberger W; Sauer R
    Strahlenther Onkol; 2000 Apr; 176(4):161-7. PubMed ID: 10812388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for anastomotic leakage after preoperative chemoradiation therapy and low anterior resection with total mesorectal excision for locally advanced rectal cancer.
    Rodríguez-Ramírez SE; Uribe A; Ruiz-García EB; Labastida S; Luna-Pérez P
    Rev Invest Clin; 2006; 58(3):204-10. PubMed ID: 16958295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies.
    Valentini V; Coco C; Cellini N; Picciocchi A; Fares MC; Rosetto ME; Mantini G; Morganti AG; Barbaro B; Cogliandolo S; Nuzzo G; Tedesco M; Ambesi-Impiombato F; Cosimelli M; Rotman M
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):371-83. PubMed ID: 11567811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation.
    Valentini V; Coco C; Cellini N; Picciocchi A; Genovesi D; Mantini G; Barbaro B; Cogliandolo S; Mattana C; Ambesi-Impiombato F; Tedesco M; Cosimelli M
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1067-75. PubMed ID: 9539561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II trial of neoadjuvant capecitabine combined with hyperfractionated accelerated radiation therapy in locally advanced rectal cancer.
    Marsh Rde W; George TJ; Siddiqui T; Mendenhall WM; Zlotecki RA; Grobmyer S; Hochwald S; Chang M; Larson B; King J
    Am J Clin Oncol; 2010 Jun; 33(3):251-6. PubMed ID: 19823074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.